We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+5.68%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$20.9B
AUM Growth
+$2.54B
Cap. Flow
+$1.55B
Cap. Flow %
7.41%
Top 10 Hldgs %
15.24%
Holding
2,978
New
379
Increased
824
Reduced
813
Closed
161

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$798M
2
XOM icon
ExxonMobil
XOM
+$189M
3
CTSH icon
Cognizant
CTSH
+$86.4M
4
MRK icon
Merck
MRK
+$80.6M
5
IART icon
Integra LifeSciences
IART
+$47.9M

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$57.5M
2
PEP icon
PepsiCo
PEP
+$55.1M
3
DG icon
Dollar General
DG
+$49.7M
4
WOOF
VCA Inc.
WOOF
+$48.1M
5
SPG icon
Simon Property Group
SPG
+$45.6M

Sector Composition

Rank Sector Weight
1 Healthcare 17.52%
2 Technology 14.11%
3 Financials 12.07%
4 Industrials 10.58%
5 Consumer Discretionary 9.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IPAR icon
1076
Interparfums
IPAR
$3.95B
$196K ﹤0.01%
5,410
SLV icon
1077
iShares Silver Trust
SLV
$28.2B
$196K ﹤0.01%
11,375
RHT
1078
DELISTED
Red Hat Inc
RHT
$196K ﹤0.01%
2,272
+85
+4% +$6.75K
GRPN icon
1079
Groupon
GRPN
$1.05B
$195K ﹤0.01%
2,493
-147
-6% -$11.3K
ISRA icon
1080
VanEck Israel ETF
ISRA
$152M
$195K ﹤0.01%
6,726
-40
-0.6% -$1.13K
XLNX
1081
DELISTED
Xilinx Inc
XLNX
$195K ﹤0.01%
3,377
+2,890
+593% +$170K
SENS icon
1082
Senseonics Holdings Inc
SENS
$262M
$194K ﹤0.01%
5,428
MZTI
1083
The Marzetti Company
MZTI
$2.96B
$192K ﹤0.01%
1,499
-50
-3% -$6.71K
KYO
1084
DELISTED
Kyocera Adr
KYO
$192K ﹤0.01%
3,447
-2,466
-42% -$133K
BAH icon
1085
Booz Allen Hamilton
BAH
$8.76B
$191K ﹤0.01%
5,413
+58
+1% +$2.07K
INDY icon
1086
iShares S&P India Nifty 50 Index Fund
INDY
$553M
$191K ﹤0.01%
5,924
SPLK
1087
DELISTED
Splunk Inc
SPLK
$191K ﹤0.01%
3,071
-340
-10% -$20.3K
CCC
1088
DELISTED
Calgon Carbon Corp
CCC
$191K ﹤0.01%
13,120
PTC icon
1089
PTC
PTC
$14.5B
$190K ﹤0.01%
+3,629
New +$192K
BMO icon
1090
Bank of Montreal
BMO
$124B
$188K ﹤0.01%
2,528
+1,067
+73% +$80.6K
GAP
1091
The Gap Inc
GAP
$7.06B
$187K ﹤0.01%
7,777
JJSF icon
1092
J&J Snack Foods
JJSF
$1.45B
$186K ﹤0.01%
1,377
JNPR
1093
DELISTED
Juniper Networks
JNPR
$185K ﹤0.01%
6,654
-8,346
-56% -$233K
AIG icon
1094
American International
AIG
$42.1B
$184K ﹤0.01%
2,961
-1,981
-40% -$127K
FMC icon
1095
FMC
FMC
$1.4B
$184K ﹤0.01%
3,060
+25
+0.8% +$1.29K
ORMP icon
1096
Oramed Pharmaceuticals
ORMP
$169M
$184K ﹤0.01%
+30,000
New +$187K
FWRD icon
1097
Forward Air
FWRD
$477M
$183K ﹤0.01%
3,860
IBN icon
1098
ICICI Bank
IBN
$107B
$183K ﹤0.01%
23,533
+20,518
+681% +$153K
DASTY
1099
DELISTED
DASSAULT SYSTEMES SA ADR
DASTY
$183K ﹤0.01%
2,128
+366
+21% +$31.5K
UNF icon
1100
Unifirst Corp
UNF
$5.37B
$181K ﹤0.01%
1,287
+240
+23% +$31.7K

Similar funds

Glenmede Trust's Q1 2017 Portfolio in Review

As of Q1 2017, Glenmede Trust held 2,978 positions worth $20.9B, up 14% from $18.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Glenmede Trust deployed $1.55B of net new capital in Q1 2017, opening 379 new positions and adding to 824 existing holdings. Its largest new stake was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 13% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Activision Blizzard, an estimated $57.5M trimmed.

  • Glenmede Trust's largest Q1 2017 buy was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.
  • Glenmede Trust added most to Johnson & Johnson in Q1 2017, an estimated $798M increase.
  • Glenmede Trust's biggest Q1 2017 reduction was Activision Blizzard, cutting an estimated $57.5M.
  • Glenmede Trust fully exited Cynosure, Inc. Class A in Q1 2017, selling an estimated $22.5M.
  • Glenmede Trust's ten largest holdings make up 15% of its $20.9B portfolio in Q1 2017.
  • Glenmede Trust opened 379 new positions and closed 161 in Q1 2017.
  • Glenmede Trust's portfolio value rose 14% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q1 2017, filed 15 May 2017.